Jun Fei Feng
Finanzdirektor/CFO bei Beijing Shenogen Pharma Group Ltd.
Profil
Jun Fei Feng is currently the CFO, Board Secretary & Deputy GM at Beijing Shenogen Pharma Group Ltd.
He previously worked as a Secretary at Beijing Hanbang Technology Corp.
Mr. Feng graduated from Central University of Finance & Economics with a graduate degree in 2008 and from Northwest University of Politics & Law with an undergraduate degree in 2005.
Aktive Positionen von Jun Fei Feng
Unternehmen | Position | Beginn |
---|---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Finanzdirektor/CFO | 01.09.2019 |
Ehemalige bekannte Positionen von Jun Fei Feng
Unternehmen | Position | Ende |
---|---|---|
BEIJING HANBANG TECHNOLOGY CORP. | Unternehmenssekretär | - |
Ausbildung von Jun Fei Feng
Northwest University of Politics & Law | Undergraduate Degree |
Central University of Finance & Economics | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BEIJING HANBANG TECHNOLOGY CORP. | Electronic Technology |
Private Unternehmen | 1 |
---|---|
Beijing Shenogen Pharma Group Ltd.
Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |